Supplementary Materials

Supplementary Material for:

Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT

Anastasia Papadopoulou, Ulrike Gerdemann, Usha L. Katari, Ifigenia Tzannou, Hao Liu, Caridad Martinez, Kathryn Leung, George Carrum, Adrian P. Gee, Juan F. Vera, Robert A. Krance, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Ann M. Leen*

*Corresponding author. E-mail: amleen@txch.org

Published 25 June 2014, Sci. Transl. Med. 6, 242ra83 (2014)
DOI: 10.1126/scitranslmed.3008825

This PDF file includes:

  • Materials and Methods
  • Fig. S1. Lack of alloreactivity of mVSTs generated for clinical use.
  • Fig. S2. In vivo expansion of T cells directed against targeted and nontargeted viral antigens.
  • Table S1. Specificity of mVSTs.
  • Table S2. Plasma cytokine concentrations before and after infusion of mVSTs (pg/ml).
  • References (5759)

[Download PDF]